[1]卢甜甜 张轶.射血分数保留性心力衰竭左心室心肌力学变化及评估的研究进展[J].心血管病学进展,2022,(4):331-334,340.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.011]
　LU Tiantian,ZHANG Yi?/html>.Changes and Evaluation of Left Ventricular Myocardial Mechanical?n Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(4):331-334,340.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.011]
点击复制

射血分数保留性心力衰竭左心室心肌力学变化及评估的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年4期
页码:
331-334,340
栏目:
综述
出版日期:
2022-04-25

文章信息/Info

Title:
Changes and Evaluation of Left Ventricular Myocardial Mechanical?n Heart Failure with Preserved Ejection Fraction
作者:
卢甜甜 张轶
(湖南师范大学附属第一医院 湖南省人民医院超声科,湖南 长沙 410011)
Author(s):
LU Tiantian;  ZHANG Yi?/html>
(Department of Ultrasound,The People’s Hospital of Hunan Provice ,The First Affiliated Hospital of Hunan Normal University,Changsha,410011,Hunan,China)
关键词:
射血分数保留性心力衰竭; 心肌力学; 超声心动图
Keywords:
Heart failure with preserved ejection fraction; Myocardial mechanics;  Echocardiography
DOI:
10.16806/j.cnki.issn.1004-3934.2022.04.011
摘要:
射血分数保留性心力衰竭（HFpEF）是一组以心肌顺应性减低、心室主动舒张和被动充盈功能障碍、左心室充盈压增高为特征的临床综合征，约占心力衰竭总数的50%。近年来HFpEF的发病率和病死率逐年上升，其心肌力学的改变和评估是心血管研究热点之一，早期诊断对该病的治疗和预后极为关键。现就HFpEF患者心肌力学的改变以及对其心脏功能评估的研究进展做一综述。
Abstract:
Heart failure with preserved ejection fraction (HFpEF) is a group of clinical syndromes characterized by decreased myocardial compliance,dysfunction of ventricular active diastolic and passive filling,and increased left ventricular filling pressure,accounting for about 50% of the total heart failure. In recent years,the incidence rate and mortality of HFpEF have increased year by year. The changes and evaluation of myocardial mechanics is one of the hot topics in cardiovascular research. Early diagnosis is very critical for the treatment and prognosis of this disease. This article reviews the changes of left ventricular myocardial mechanics and the evaluation of cardiac function in HFpEF patients.

参考文献/References:


[1]Huis In’t Veld AE,de Man FS,van Rossum AC, et al. How to diagnose heart failure with preserved ejection fraction :the value of invasive stress testing[J]. Neth Heart J,2016,24(4):244-251.

[2] Lam CSP,Arnott C,Beale AL,et al. Sex differences in heart failure[J]. Eur Heart J,2019,40(47):3859-3868c.

[3]Morishita T,Takeishi N,Ii S,et al. Effects of left ventricular hypertrophy and myocardial stiffness on myocardial strain under?preserved?ejection?fraction[J]. Ann Biomed Eng,2021,49(7):1670-1687.

[4] Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC [J]. Eur J Heart Fail,2016,18(8):891-975.

[5]Sun J, Tai S, Guo Y, et al. Sex differences in characteristics and outcomes in elderly heart failure patients with preserved ejection fraction: a Post-hoc analysis from TOPCAT [J]. Front Cardiovasc Med,2021,8:721850.

[6]McDonagh TA,Metra M,Adamo M,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J,2021,42(36):3599-3726.

[7]Nagueh SF,Smiseth OA,Appleton CP,et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography:an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J]. Eur Heart J Cardiovasc Imaging,2016,17:1321-1360.

[8] van Heerebeek L,Paulus WJ. Understandingheart failure with preserved ejection fraction:where are we today[J]. Netherlands Heart J,2016,24(4):227-236.

[9] Pieske B,Tsch?pe C,de Boer RA,et al. How to diagnose heart failure with preserved ejection fraction:the HFA-PEFF diagnostic algorithm:a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)[J]. Eur Heart Fail J,2020,22(3):391-412.

[10] van Riet EE,Hoes AW,Wagenaar KP,et al. Epidemiology of heart failure:the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review[J]. Eur J Heart Fail,2016,18(3):242-252.

[11] Heinzel FR,Hohendanner F,Jin G,et al. Myocardial hypertrophy and its role in heart failure with preserved ejection fraction[J].Appl Physiol,2015,119(10):1233-1242.

[12] 周福亮,贾大林. 射血分数保留性心力衰竭与内皮功能障碍[J]. 中国老年学杂志,2018,38(19):4852-4855.

[13] González-López E,Gallego-Delgado M,Guzzo-Merello G,et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction[J].Eur Heart J,2015,36(38):2585-2594.

[14] Frisk M,Le C,Shen X,et,al.Etiology-dependent impairment of diastolic cardiomyocyte calcium homeostasis in?heart?failure?with?preserved?ejection?fraction[J]. Am Coll Cardiol,2021, 77(4):405-419.

[15] Mishra S,Kass DA. Cellular and molecular pathobiology of?heart?failure?with?preserved?ejection?fraction[J].Nat Rev Cardiol,2021,18(6):400-423.

[16] Shi H,Han Q,Xu J, et al. Urotensin Ⅱ induction of neonatal cardiomyocyte hypertrophy involves the CaMKⅡ/PLN/SERCA 2a signaling pathway[J] . Gene,2016,583(1):8-14.

[17] Baral R,Loudon B,Frenneaux MP,et al. Ventricular-vascular coupling in heart failure with preserved ejection fraction:a systematic review and meta-analysis[J]. Heart Lung,2021,50(1):121-128.

[18] Shah AM,Claggett B,Sweitzer NK,et al. Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone[J]. Circulation,2015,132(5):402-414.

[19] Miljkovik LV,Spiroska V. Heart failure with preserved ejection fraction - concept,pathophysiology,diagnosis and challenges for treatment[J]. Open Access Maced J Med Sci,2015,3(3):521-527.

[20] Yancy CW,Jessup M,Bozkurt B,et al. 2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. Am Coll Cardiol,2013,62(16):e147-e239.

[21] Ye Z,Miranda WR,Yeung DF,et al. Left atrial strain in evaluation of?heart?failure?with?preserved?ejection?fraction[J]. Am Soc Echocardiog,2020,33(12):1490-1499.

[22] Melenovsky V,Hwang SJ,Redfield MM,et al. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction[J]. Circ Heart Fail,2015,8(2):295-303.

[23] Almeida P,Rodrigues J,Lourenco P,et al. Left atrial volume index is critical for the diagnosis of heart failure with preserved ejection fraction[J]. Cardiovasc Med (Hagerstown) ,2018,19(6):304-309.

[24] 李娟,张勇,王健.肥胖和阻塞性睡眠呼吸暂停综合征对左室质量及左室几何构型的影响[J]. 中西医结合心脑血管病杂志,2021,19(1):133-138.

[25] D’Andrea A,Radmilovic J,Ballo P,et al. Left ventricular hypertrophy or storage disease? the incremental value of speckle tracking strain bull’s-eye[J]. Echocardiography,2017,34(5):746-759.

[26] Ran H,Schneider M,Pistritto AM,et al. Echocardiographic evaluation of left ventricular filling pressures in patients with pulmonary hypertension[J]. Int J Cardiovasc Imaging,2019,35(5):861-868.

[27] Narang A,Mor-Avi V,Prado A,et,al. Machine learning based automated dynamic quantification of left heart chamber volumes[J]. Eur Heart J Cardiovasc Imaging,2019,20(5):541-549.

[28] Sharifov OF,Schiros CG,Aban I,et al. Diagnostic accuracy of tissue Doppler index E/e’ for evaluating left ventricular filling pressure and diastolic dysfunction/heart failure with preserved ejection fraction:a systematic review and meta-analysis[J]. Am Heart Assoc,2016,25,5(1):e002530.

[29] Koestenberger M,Friedberg MK,Nestaas E,et al. Transthoracic echocardiography in the evaluation of pediatric pulmonary hypertension and ventricular dysfunction[J]. Pulm Circ,2016,6(1):15-29.

[30] 孙丹丹,侯颖,侯传举,等. 应用三尖瓣血流速度图评估肺动脉高压的研究[J]. 中国医学影像学杂志,2017,25(1):13-16.

[31] Dzhioeva O,Belyavskiy E. Diagnosis and management of patients with heart failure with preserved ejection fraction (HFpEF):current perspectives and recommendations[J]. Ther Clin Risk Manag,2020,16:769-785.

[32] Notomi Y,Isomura T,Kanai S,et al. Pre-operative left ventricular torsion,QRS width/CRT,and post-mitral surgery outcomes in patients with nonischemic,chronic,severe secondary mitral regurgitation[J]. JACC Basic Transl Sci,2016,1(4):193-202.

[33]Zhang Y,Li SY,Xie JJ,et al. Twist/untwist parameters are promising evaluators of myocardial mechanic changes in heart failure patients with preserved ejection fraction[J]. Clin Cardiol,2020,43(6):587-593.

[34] Sakane K,Kanzaki Y,Tsuda K,et al. Disproportionately low BNP levels in patients of acute?heart?failure?with?preserved?vs reduced?ejection?fraction[J]. Int J Cardio,2021,327(5):105-110.

[35] Carubelli V1,Lombardi C,Lazzarini V,et al. N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure[J]. Cardiovasc Med (Hagerstown),2016,17(11):828-839.

相似文献/References:

[1]孙慧雪 郑美芳 李海 孙磊 顾翔.远程医疗应用于射血分数保留性心力衰竭的现状及进展[J].心血管病学进展,2020,(3):251.[doi:10.16806/j.cnki.issn.1004-3934.20.03.009]
　SUN Huixue,ZHENG Meifang,LI Hai,et al.Status Progress of Telemedicine in Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2020,(4):251.[doi:10.16806/j.cnki.issn.1004-3934.20.03.009]
[2]菲尔凯提·玉山江李昊穆叶赛·尼加提.射血分数保留性心力衰竭合并糖尿病的研究进展[J].心血管病学进展,2020,(4):373.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.011]
　FEIERKAITI·Yushanjiang,LIHao,MUYESAI.Nijiati.Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2020,(4):373.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.011]
[3]高可 杨蕾 姚新叶 郑小璞.射血分数保留性心力衰竭动物模型的研究进展[J].心血管病学进展,2020,(8):834.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.013]
　GAO Ke,YANG Lei,YAO Xinye,et al.Advances in Animal Models ofHeart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2020,(4):834.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.013]
[4]刘春秋 熊双 刘剑刚 董国菊.射血分数保留性心力衰竭的诊断的研究进展[J].心血管病学进展,2021,(9):784.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
　LIU Chunqiu,XIONG Shuang,LIU Jiangang,et al.Diagnosis of Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2021,(4):784.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[5]宋雨 李耘 马丽娜.老年人衰弱和射血分数保留性心力衰竭病理生理学机制的研究进展[J].心血管病学进展,2022,(1):38.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.010]
　SONG Yu,LI Yun,MA Lina.Pathophysiological Mechanisms of Frailty and Heart Failure with Preserved Ejection Fraction in the Elderly[J].Advances in Cardiovascular Diseases,2022,(4):38.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.010]
[6]赵菲 刘永铭.抗炎类药物对射血分数保留性心力衰竭患者心外膜脂肪组织的影响[J].心血管病学进展,2022,(1):41.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.011]
　ZHAO Fei,LIU Yongming.Effects of Anti-Inflammatory Drugs on Epicardial Adipose Tissue in Patients with Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(4):41.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.011]
[7]张文珺 牛小伟 刘永铭.m6A甲基化在射血分数保留性心力衰竭中的作用的研究进展[J].心血管病学进展,2022,(1):44.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.012]
　ZHANG Wenjun,NIU Xiaowei,LIU Yongming.m6A RNA Methylation in Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(4):44.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.012]
[8]聂琼 吴镜.射血分数保留性心力衰竭：从机制到治疗[J].心血管病学进展,2022,(3):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
　NIE Qiong,WU Jing.Heart Failure with Preserved Ejection Fraction:from Mechanism to Treatment[J].Advances in Cardiovascular Diseases,2022,(4):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
[9]时利英 蒋晖.运动训练在射血分数保留性心力衰竭的应用进展[J].心血管病学进展,2022,(4):344.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.014]
　SHI liying,JIANG hui.Exercise-Based Rehabilitation in Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(4):344.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.014]
[10]石玉姣 熊双 刘春秋 杨晨光 董国菊 刘剑刚.射血分数保留性心力衰竭潜在的分子机制及治疗靶点[J].心血管病学进展,2022,(5):423.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.010]
　SHI Yujiao,XIONG Shuang,LIU Chunqiu,et al.Potential Molecular Mechanisms and Therapeutic Target in Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(4):423.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.010]

更新日期/Last Update: 2022-05-13